Order results by:
Issue | Title | |
Vol 2, Issue 1 (2022) | Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing | Abstract PDF (Eng) similar documents |
N. A. Shnayder, A. K. Abdyrakhmanova, R. F. Nasyrova | ||
"... Antipsychotics (APs) are a class of psychotrophic medication primarily used to manage psychosis ..." | ||
Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) similar documents |
A. K. Abdyrakhmanova, R. F. Nasyrova | ||
"... of antipsychotics (APs). Long-term use of APs increases the risk of developing adverse drug reactions (ADRs ..." | ||
Vol 2, Issue 1 (2022) | Clinical Case of a 36-Year-Old Man with Treatment-Resistant Paranoid Schizophrenia: Personalized Therapy Selection | Abstract PDF (Eng) similar documents |
L. P. Linova, A. A. Torgovtsev, O. V. Limankin, R. F. Nasyrova | ||
"... of antipsychotics (APs). Long-term use of APs increases the risk of developing adverse drug reactions (ADRs ..." | ||
Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) similar documents |
S M. Osipova, N. A. Shnayder | ||
"... of antipsychotics (APs). Long-term use of APs increases the risk of developing adverse drug reactions (ADRs ..." | ||
Vol 2, Issue 2 (2022) | Application of Antipsychotic Medication: Gender Differences in Tolerance and Medication Response | Abstract PDF (Eng) similar documents |
L. N. Gorobets, N. D. Semenova, A. V. Litvinov | ||
"... This paper covers the role of gender factor in the efficacy and tolerance of antipsychotic therapy ..." | ||
Vol 2, Issue 1 (2022) | PCR-based Approach for Determining the Genetic Risk Factors of Antipsychotic-Induced Metabolic Disorders | Abstract PDF (Eng) similar documents |
K. O. Mironov, I. I. Gaponova, V. I. Korchagin, A. S. Esman, E. A. Dunaeva, V. A. Zhivotova, V. S. Dobrodeeva, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
"... The antipsychotic-induced metabolic disorders (AIMD) are common side effects during the treatment ..." | ||
Vol 2, Issue 2 (2022) | Clinical Case of a 36-year-old Patient with Paranoid Schizophrenia and Drug-Induced QT Prolongation | Abstract PDF (Eng) similar documents |
N. M. Zhuravlev, A. P. Otmachov, A. E. Bartasinskaya | ||
"... of schizophrenia. One potentially fatal antipsychotic-induced adverse reaction is drug[1]induced long QT syndrome ..." | ||
1 - 7 of 7 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)